A Data Scientist at Pfizer plays a pivotal role in transforming complex biological, clinical, and commercial data into actionable insights that directly impact human health. Operating within one of the world's premier biopharmaceutical companies, you will work at the intersection of advanced analytics, machine learning, and healthcare. Your contributions will help accelerate drug discovery, optimize clinical trial designs, streamline global supply chains, and drive sophisticated commercial go-to-market strategies.
The scale of data at Pfizer is immense, ranging from genomic sequences and patient health records to global market tracking and digital telemetry. As a Data Scientist, your challenge is not just to build highly accurate models, but to design scalable data products that operate within a highly regulated global environment. This requires a unique blend of technical rigor, domain curiosity, and the ability to collaborate across diverse global teams of clinicians, engineers, and business leaders.
Ultimately, working as a Data Scientist at means your models and insights have a direct line of sight to improving patient lives. Whether you are optimizing a digital marketing funnel for a life-saving vaccine or deploying deep learning models to identify drug targets, your work carries profound real-world significance. It is a highly demanding yet exceptionally rewarding environment that requires continuous learning and operational excellence.
Telephonic Screening
reportedRounds outside the standard loop often open with something deliberately under-specified: a loose business problem, an open question about a product area, a dataset described in one sentence. The common failure is surveying, listing six plausible approaches and committing to none of them. The thing that separates a strong answer is scoping out loud. State what you are treating as the goal, name the metric you would move, say what you are choosing not to do and why, then take one path through to an actual answer. An interviewer can follow you down a narrow path. Nobody can grade a menu.
What to demonstrate
- Whether you turn an ambiguous prompt into a stated question with a measurable outcome before doing any work
- The judgement visible in what you cut, and whether you say why you cut it rather than silently dropping it
- Whether you land on a concrete recommendation with its caveat attached, rather than an unranked set of options
How to prepare
- Take three vague prompts, such as 'is this feature working', 'why did retention drop', and 'should we expand into a new segment'. For each, write one sentence of goal, one primary metric with its window, and two things you are explicitly not doing.
- Practise giving the recommendation first and the reasoning second, in five minutes. Loosely defined rounds are usually time-boxed, and an answer that arrives last often does not arrive.
- Keep a running assumption list as you talk, on paper or in the shared doc, so the interviewer can challenge one assumption instead of your whole answer.
Technical Evaluation
reportedMuch of what gets scored here happens out loud while you type. Nobody can see your reasoning inside a half-written query, so five silent minutes read as being stuck even when they are not. State the plan in plain language first: which tables, what grain you are aggregating to, and the one filter that defines the population. Then write it. The narration doubles as insurance, because a wrong plan gets caught early and cheaply while a wrong query gets caught at the end with no time left to redo it. A timed statistics section, where one exists, is a separate test with its own clock.
What to demonstrate
- Whether the query you write matches the plan you just described
- What you do with a hint, meaning whether the correction gets absorbed or the first approach gets defended
- Whether you can debug your own wrong output by reading the result set and naming which part of the query produced the anomaly
How to prepare
- Solve three problems while screen-sharing into a recording, then watch it back and mark every stretch longer than thirty seconds where you said nothing
- Practise compressing the plan into one sentence before typing, then check afterwards whether the finished query actually matched it
- Time yourself on statistics questions that carry a business reading, such as what a confidence interval does and does not claim, rather than re-reading notes without a clock
Functional Round
reportedAn added round often puts you in front of someone outside the core hiring team: a partner engineer, a product owner, a domain expert, sometimes a more senior manager. The question they are really asking is not whether you can do the work but whether they would trust a number that came from you. That changes what a good answer looks like. Lead with what the decision cost and what it changed, keep the method available but not central, and be plain about the limits of your evidence. Overstating a result is the fastest way to lose this round.
What to demonstrate
- Whether you can explain a technical choice to someone who will never read your code, without either flattening it into nothing or hiding inside jargon
- Honesty about evidence strength: what the analysis establishes, what it only suggests, and what it cannot say at all
- How you take disagreement, specifically whether you update on a good objection, hold your position with reasons, or fold on contact
How to prepare
- Write the two-sentence version of your most technical project for a non-specialist, then check that neither sentence needs a method name to make sense.
- For one result you are proud of, write the strongest objection someone could raise and a response that concedes the part of it that is correct.
- Prepare one decision that turned out to be wrong: how you found out, what it cost, and what you changed afterwards. A senior cross-functional interviewer asks for this more often than a technical one does.
Behavioral Round
reportedRounds of this kind usually include one question about work that did not go well, and it is the part that carries the most information. Anyone can narrate a shipped win. What the interviewer learns from a project that stalled is how you behave without a result to hide behind: whether you noticed the problem yourself, how long it took, and who you told. Answers that route the failure onto a data pipeline or a reorganisation close the topic without answering it, and the follow-up comes back to your own part.
What to demonstrate
- Whether you found the error yourself or someone else found it, and how long it sat before anyone knew
- What you changed afterwards, stated as a check you now run rather than a lesson you now believe
- Whether the mistake you choose has real cost attached, such as a quarter of misdirected roadmap or a metric that was reported upward, instead of one that flatters you
How to prepare
- Choose a failure you caught yourself and be ready to say what tipped you off. A story where someone else caught it is still usable, but you will be asked why you missed it.
- Write down the check you added afterwards and where it lives now, so the correction is a concrete artefact rather than a resolution.
- Rehearse saying the cost out loud. Candidates shrink the number by instinct once the interviewer is in the room.
PracHub editorial advice for the preparation topics above.
Immortal time in adherence, treatment, and enrolment definitions
Classifying members as adherent, treated, or programme-enrolled requires them to survive and stay covered long enough to accumulate the defining events. That guaranteed event-free interval is assigned to the exposed group, so the exposure looks protective for reasons that have nothing to do with the treatment. Adherence studies are the classic case: measuring 12-month proportion of days covered and then comparing mortality builds survival into the exposure definition. Use time-varying exposure or a landmark analysis with the classification window excluded from follow-up.
Pre-post evaluation on a high-cost or high-risk cohort
Cohorts selected on an extreme value of the outcome regress toward the mean on their own. Members identified as the top 1 percent of spend in one year spend far less the next, whether or not anyone intervenes, because the selecting year captured both chronic severity and one-off events. A pre-post design on such a cohort will report savings every time. A concurrent comparison group selected by the same rule in the same period, or a regression discontinuity at the selection threshold, is the minimum credible design.
SQL that silently fans out on a one-to-many join
State the grain of each table and the grain you want in the result before writing the join. Pre-aggregate the many side to the join key, or use EXISTS or a window function, and verify with a row count against COUNT(DISTINCT id) rather than trusting that the numbers look plausible.
Naming a model class before naming the deployment constraints
Set out the latency budget, the label delay, the retraining cadence, the interpretability requirement and the number of labelled examples, then pick the model that fits them. A boosted-tree answer to a problem where each decision must be explained to the affected user is a well-executed answer to the wrong question.
Choose a category, try a prompt, then open its approach, worked solution or follow-up when you need it.
What validation strategies do you employ to ensure your models general…
What validation strategies do you employ to ensure your models generalize well to unseen global populations or markets?
Approach
- Quantify uncertainty explicitly rather than reporting a point estimate alone.
- Translate the result into the decision it informs, in one plain sentence.
- Say what the estimate is of, and over what population it generalises.
Follow-up
- How would you explain this result to someone who does not know statistics?
- What sample size would you need to detect an effect half this size?
Explain the difference between bagging and boosting, and describe a sc…
Explain the difference between bagging and boosting, and describe a scenario where bagging would outperform boosting.
Approach
- Quantify uncertainty explicitly rather than reporting a point estimate alone.
- Sanity-check the answer against a simple bound or a simulated case.
- Write down the assumption the method needs before you use the method.
Follow-up
- Which assumption here is most likely to be violated in practice?
- What sample size would you need to detect an effect half this size?
How do you address extreme class imbalance when modeling rare events, …
How do you address extreme class imbalance when modeling rare events, such as rare adverse drug events or low-rate digital conversions?
Approach
- Sanity-check the answer against a simple bound or a simulated case.
- Write down the assumption the method needs before you use the method.
- Quantify uncertainty explicitly rather than reporting a point estimate alone.
Follow-up
- How would you explain this result to someone who does not know statistics?
- What sample size would you need to detect an effect half this size?
Walk me through the mathematical intuition and trade-offs of a machine…
Walk me through the mathematical intuition and trade-offs of a machine learning algorithm you have used extensively in a past project.
Approach
- Pick an evaluation metric that matches the cost of each error type, not a default.
- Set a baseline first, so any model has something honest to beat.
- Frame the prediction: the label, the moment of prediction, and the action it triggers.
Follow-up
- How would you choose the decision threshold, and who owns that choice?
- What would you monitor after launch to know the model is still valid?
How do you set up automated monitoring to detect data drift and model …
How do you set up automated monitoring to detect data drift and model degradation post-deployment?
Approach
- Frame the prediction: the label, the moment of prediction, and the action it triggers.
- Check what information would not exist at prediction time, and exclude it.
- Set a baseline first, so any model has something honest to beat.
Follow-up
- How would you choose the decision threshold, and who owns that choice?
- Where could label leakage enter this setup?
Proportion of days covered with shifted, truncated refill intervals
pharmacy_claim has fill_id, member_id, therapeutic_class_code, fill_date, days_supply, reversal_flag, reversed_fill_id. For one therapeutic class and a fixed 12-month window, compute proportion of days covered per member: distinct days on which a dispensed days_supply covers the day, divided by days from the member's first in-window fill through the window end. An early refill shifts coverage forward rather than stacking, and coverage is truncated at the window end. Drop both rows of every reversed pair. Return member_id, pdc, and the share at pdc >= 0.80 among members with at least 2 fills and at least 91 days of follow-up.
Approach
- Remove reversals as pairs first. Drop every row with reversal_flag true, and also drop the fill_ids those rows point at through reversed_fill_id. Dropping only the flagged row leaves a dispense that was never collected in the exposure.
- Walk fills per member in fill_date order carrying a cursor: start = max(fill_date, previous_end + 1 day), end = start + days_supply - 1. The shift is path dependent, so a plain cumsum over days_supply does not reproduce it. Use itertools.accumulate or a per-member loop over numpy arrays, not a row-wise apply over the whole frame.
- Truncate the last interval at the window end before measuring. Without truncation a 90-day fill dispensed on the final day pushes the covered-day count past the denominator and PDC above 1.0.
- Use the denominator the definition states: first in-window fill_date through window end, inclusive. Not a flat 365, and not first fill to last fill, which is a different metric that rewards early discontinuation.
- Apply the eligibility filter before computing the >= 0.80 share, and report the size of that denominator next to the share. A share without its denominator is not reviewable.
Worked solution 40 min
- Filter to the therapeutic class and the window, then remove reversed pairs by dropping flagged rows and the fill_ids in reversed_fill_id.
- Sort by member_id, fill_date. Per member, accumulate start = max(fill_date, prior_end + 1 day) and end = start + days_supply - 1.
- Clip every interval's end at the window end and drop intervals whose start is past it.
- Covered days per member = sum of (end - start + 1) over the shifted intervals, which are disjoint by construction.
- Denominator = (window_end - first_fill_date).days + 1. Divide, then filter to members with >= 2 fills and denominator >= 91 and compute the share at or above 0.80.
Follow-up
- How does PDC differ from medication possession ratio, and which of the two can exceed 1.0?
- A member switches to a different ingredient inside the same therapeutic class mid-window. Should the intervals chain, and what does that do to the class-level number?
- Members who die or lose coverage mid-window get a short denominator and often a high PDC. If you then compare mortality by adherence category, what bias have you built in and how do you remove it?
How would you optimize a SQL query that is running slowly due to massi…
How would you optimize a SQL query that is running slowly due to massive table joins across distributed databases?
Approach
- Handle the rows that do not match: a LEFT JOIN with a NULL check is usually the question.
- Say which table is the grain you start from, and join outward from it.
- State the window function and its partition and ordering out loud before writing it.
Follow-up
- How would you verify this result without re-running the same query?
- What breaks if events arrive late or out of order?
Write a program to find the first non-repeating character in a stream …
Write a program to find the first non-repeating character in a stream of data and discuss its time and space complexity.
Approach
- Say which table is the grain you start from, and join outward from it.
- Compute rates by summing numerator and denominator separately, never by averaging rates.
- State the window function and its partition and ordering out loud before writing it.
Follow-up
- How would you verify this result without re-running the same query?
- What breaks if events arrive late or out of order?
Deduplicate claim versions before totalling allowed amounts
medical_claim_line holds one row per service line per claim version: claim_line_id, claim_id, claim_version, frequency_code (1 original, 7 replacement, 8 void), member_id, service_start_date, procedure_code, allowed_amount, claim_status and adjudicated_at. Adjusted claims appear more than once, so summing every row double counts them. Return total allowed_amount by procedure_code for service_start_date in Q1 2025, counting only lines with claim_status 'paid' on the surviving version of each claim, which is the highest claim_version per claim_id, and dropping the claim entirely when that surviving version carries frequency_code 8. Resolve survivorship with a window function, not a self-join.
Approach
- Resolve survivorship at claim_id, not claim_line_id. Carry MAX(claim_version) OVER (PARTITION BY claim_id) alongside every line and keep lines where claim_version equals it, because a replacement version can contain a different number of lines than the original.
- Read the frequency_code of the surviving version only. A frequency_code 8 removes the claim outright; it does not revert payment to the prior version, so a void must delete the claim rather than promote version n-1.
- Apply claim_status and the date filter after survivorship is resolved. Filtering paid lines first can strip the surviving version and silently elect a superseded one.
- Group by procedure_code and sum allowed_amount, then state the paid-through date on the output because Q1 amounts keep moving until adjudication runout completes.
- Sanity check the shrinkage: report how many claim_ids and how many dollars the dedup removed, so the reviewer can see the step did something.
Worked solution 20 min
- Build a CTE that adds surviving_version = MAX(claim_version) OVER (PARTITION BY claim_id) and surviving_freq = the frequency_code of the row at that version, to every line.
- Filter to claim_version = surviving_version so all lines of the surviving version survive together.
- Drop claims whose surviving_freq is 8, then apply claim_status = 'paid' and service_start_date between 2025-01-01 and 2025-03-31.
- Group by procedure_code, sum allowed_amount, and emit the count of distinct claim_ids contributing.
- Run the naive SUM over all rows beside it and report the difference as the double count that was removed.
Follow-up
- Two rows share a claim_id and claim_version but differ on adjudicated_at. What do you do, and what does that imply about the extract?
- How does the query change if the request is allowed_amount by paid_date rather than service_start_date, and which basis does a finance reconciliation want?
- A void arrives for a claim already published in a closed month. How do you restate without rewriting history in the warehouse?
Write a Python script to parse, clean, and restructure an unstructured…
Write a Python script to parse, clean, and restructure an unstructured JSON log file containing user engagement telemetry.
Approach
- Fix the population and the time window before naming any metric.
- Name one primary metric, then the guardrail that stops it being gamed.
- Decompose the metric into the rates that drive it, and say which one you would check first.
Follow-up
- How would you detect that the metric is being gamed rather than genuinely improving?
- What would you do if the primary metric and the guardrail moved in opposite directions?
What is your approach to versioning datasets and models to ensure repr…
What is your approach to versioning datasets and models to ensure reproducibility in a highly regulated validation environment?
Approach
- State your assumptions explicitly before working the problem.
- Work from the decision backwards to the evidence you would need.
- Say what you would check first and why it is the highest-information step.
Follow-up
- What assumption would you test first?
- How would you know your answer was wrong?
Score trial sites without rewarding enrollment that does not stick
A clinical operations group ranks sites on subjects randomized per activated site-month, using study_subject_visit (study_id, site_id, subject_id, arm_code, randomization_ts, site_activation_date, visit_name, visit_number, visit_status, primary_endpoint_value, protocol_deviation_flag, deviation_severity). Bottom-ranked sites lose allocation on the next study. Define the primary metric, two guardrails, the handling of sites activated too recently to rank, and the estimator you rank on. Then state what a site under allocation pressure does to the number, and which guardrail sees it.
Approach
- Move the numerator from randomized to randomized and retained through the protocol-defined primary endpoint visit. A subject who randomizes and withdraws consumes screening, drug supply and monitoring while contributing nothing to the analysis population, so counting them rewards the wrong behaviour precisely when a site is under pressure.
- Build the denominator as exposure, not sites: site-months from site_activation_date to the earlier of period end and database lock, per study. Ranking on a raw count instead of a rate confuses a large site with a fast one.
- Handle young sites by reporting rather than dropping. Sites with fewer than a stated minimum exposure are shown in an insufficient-exposure band, because excluding them is how a non-enrolling tail disappears from a scorecard, and the non-enrolling tail is usually the larger operational problem.
- Rank on a shrunken estimate, not the raw ratio. With a few site-months of exposure the ratio has enormous variance, and a site with two site-months and one randomization will top an unshrunken table. Partial pooling toward the study mean, or a simple empirical-Bayes posterior mean, prevents rank being an artefact of small exposure.
- Pick guardrails that read the two pressure responses. A site that loosens eligibility judgement shows an implausibly low screen-failure rate, computed as subjects with randomization_ts NULL and visit_status screen_failed over subjects screened. A site that pushes visits to hit counts shows up in major protocol deviations per 100 completed visits, reported separately from minor ones because a single major deviation can remove a subject from the per-protocol set.
- Report the companion the median hides: the share of activated sites with no randomization by day 90. A median computed only over sites that eventually randomized is silent about the sites that never did.
Worked solution 30 min
- Define the numerator as subjects with non-null randomization_ts whose primary endpoint visit reaches visit_status completed with a non-null primary_endpoint_value, per study and site.
- Compute site-months of exposure from site_activation_date to period end or database lock, and set the minimum exposure below which a site is banded rather than ranked.
- Compute the raw rate, then the shrunken estimate by partial pooling toward the study mean, and print both columns side by side so the shrinkage is visible rather than hidden.
- Specify the two guardrails with numerator, denominator and window, keeping major and minor deviations as separate series.
- Add the no-randomization-by-day-90 share across all activated sites, so the non-enrolling tail appears on the same page as the ranking.
Follow-up
- A site has the best randomized-and-retained rate and the worst major deviation rate. What do you recommend, and what would change your answer?
- Your shrunken ranking moves a site from 3rd to 14th. How do you explain shrinkage to the site's operations lead in two sentences?
- Primary endpoint retention takes 18 months to observe. What do you rank on in the meantime, and what bias does that interim choice introduce?
Readmission rate rose while every facility improved
Quarter over quarter the 30-day unplanned readmission rate for an attributed population rose from 14.2 to 15.1 percent, yet all eleven facilities in encounter show a flat or falling rate over the same period. You have encounter (facility_id, admit_ts, discharge_ts, encounter_type, admission_type, discharge_disposition, drg_code, is_planned_admission, index_encounter_id) and twelve months of prior medical_claim_line for comorbidities. Explain the direction reversal numerically, and state what the population-level number should be reported as instead.
Approach
- Confirm the reversal is arithmetic, not a definition difference, by recomputing both the facility rates and the pooled rate from the same query with the same index-stay exclusions.
- Decompose the pooled change exactly with a Kitagawa split. With facility weights w and within-facility rates r, the change equals the sum over facilities of (w_1 - w_0) times (r_0 + r_1)/2, the mix term, plus the sum of (w_0 + w_1)/2 times (r_1 - r_0), the within term. If the mix term exceeds the total change and the within term is negative, the reversal is volume shifting toward facilities with higher baseline rates.
- Ask why the weights moved. Check index-stay volume by facility, and check whether an exclusion changed behaviour: acute-to-acute transfers (discharge_disposition 'transfer_acute') must not open an index stay, and if one facility began transferring more, its denominator shrinks toward its sickest retained patients.
- Check case mix inside the facilities too, using drg_code and comorbidities drawn from the 12 months of claims before admit_ts, excluding complications of the index stay itself. A facility rate can be flat while its case mix worsens.
- Replace the raw pooled rate with an observed over expected ratio, where expected is the sum of predicted probabilities from a model fitted on age, sex and prior comorbidities. Raw rates are not comparable across a population whose facility and case mix is moving.
Follow-up
- Your O/E ratio is 1.04 with a 95 percent interval of 0.96 to 1.13. What does that let you say to a facility, and what does it not?
- If one facility contributes 40 percent of index stays, how does that change how you present the decomposition?
- How would you handle a member with two index stays in the quarter, where the second is also a readmission from the first?
For a candidate whose interviews will centre on A/B testing, metric movement and causal claims. Design comes before arithmetic, arithmetic before analysis, and the week ends by rehearsing the readout rather than the derivation.
Prepare, practise & reflect
One practical outcome each day. Spend longer where you need it.
0 / 7 done01Design one test end to end on paper
- Take a single feature change and write the full design: randomization unit, the exact point of exposure, the primary metric with its grain, guardrails, allocation, planned duration, and the decision rule committed before any data exists.
- Write why the randomization unit must sit at or above the level where treatment can spill over, and give one case where user-level randomization is still contaminated (shared accounts or devices, or two participants in the same marketplace).
- State in advance what you will do if the primary metric is flat while a secondary metric is significant.
Deliverable: A one-page test design with a decision rule written before launch.
Practice prompt ↗Practice prompt ↗Practice prompt ↗Worked solution ↗02Power arithmetic until it is automatic
- Compute required sample size per arm for a binary metric with the normal approximation, n is approximately 2 times (z for alpha/2 plus z for power) squared times p(1 minus p) divided by delta squared, for baselines of 2, 10 and 40 percent at a 5 percent relative lift, and note that for a fixed relative lift the requirement falls as the baseline rises because delta grows proportionally with p.
- Redo the calculation for a continuous metric using variance in place of p(1 minus p), and show why a heavy-tailed quantity such as revenue per user needs either far more traffic or a capped version with a stated cap.
- Convert one of the results into weeks given a weekly eligible traffic figure, then list the two honest ways to shorten it (accept a larger detectable effect, or reduce variance) and write why quietly lowering the power target is a decision to miss more real wins, not a speedup.
Deliverable: A small script or sheet that maps baseline, minimum detectable effect, alpha and power to sample size and weeks, cross-checked against a published calculator.
Practice prompt ↗Practice prompt ↗Practice prompt ↗03Variance and the unit-of-analysis problem
- Take a ratio metric whose denominator is not the randomization unit (clicks per session, randomized by user) and compute the standard error twice, once naively at session level and once by the delta method or a user-level bootstrap, then record how much the naive version understates it.
- Implement CUPED on simulated data: choose a pre-period covariate X measured before assignment, estimate theta as Cov(Y, X) divided by Var(X), and analyse Y minus theta times (X minus its mean) in place of Y. Confirm the variance of the adjusted outcome equals the raw variance multiplied by one minus the squared correlation between Y and X, so a correlation of 0.45 removes about 20 percent of the variance and not 80.
- Now run that simulation a few hundred times and confirm the adjusted effect estimate is unbiased for the same effect rather than numerically identical to the raw one. Within any single run the two differ, sometimes by a large fraction of the true effect, because the two arms' pre-period covariate means never coincide exactly in a finite sample; they agree in expectation, which is the property that matters and the one to state out loud.
Deliverable: A notebook showing the adjusted estimator with a measurably smaller variance than the raw one, plus a repeated-simulation table showing the two estimators agreeing on average while differing run by run.
Practice prompt ↗Practice prompt ↗04Validity threats you can actually test for
- Run a sample ratio mismatch check as a chi-square goodness-of-fit test against the intended allocation, and write the three causes you would chase first (assignment logged before exposure, an arm-specific redirect or load failure, bot filtering applied asymmetrically).
- Simulate peeking: generate A/A data, test daily at alpha 0.05 across 14 looks, record the inflated false positive rate, then apply an alpha-spending boundary or commit to a fixed horizon and confirm the rate returns to nominal.
- Write how you would separate a novelty effect from a durable lift using the treatment effect plotted against days since first exposure, and what shape would change your recommendation.
Deliverable: One table showing the peeking false positive rate before and after correction, plus a written SRM triage list.
Practice prompt ↗Practice prompt ↗Worked solution ↗05When randomization is not available
- Write the identifying assumption for difference-in-differences (parallel trends in the absence of treatment), then plot pre-period trends for two candidate control groups and justify rejecting one of them.
- Design a switchback test for a change where user-level randomization would leak across participants, choosing a time-block length against the carryover you expect and saying how you would detect carryover in the data.
- List what an interrupted time series or a synthetic control buys you and the one thing neither can rule out: an unobserved shock that coincides with the launch.
Deliverable: A one-page memo recommending a single quasi-experimental design and naming its weakest assumption explicitly.
Practice prompt ↗Practice prompt ↗06The readout query
- Write the assignment-to-exposure join that returns exactly one row per unit per experiment, and handle units appearing in both arms by excluding and counting them rather than silently keeping one.
- Compute the per-arm metric, its variance and the relative lift with a confidence interval in SQL, then reproduce the identical numbers in a notebook as a cross-check.
- Add a segment breakdown and write the sentence that keeps it from being p-hacking: segments declared in advance, everything else reported as exploratory and corrected for multiplicity.
Deliverable: A single query that outputs the full readout table, matched to a notebook recomputation.
Practice prompt ↗Practice prompt ↗07Present it to someone who will not read the appendix
- Give a 10-minute readout of a real or simulated experiment in the order decision, number, uncertainty, caveat.
- Have your listener ask "can we ship it" in the case where the primary is flat and a guardrail moved, and answer with a recommendation rather than a request for more data.
- Rewrite your opening line so the recommendation lands before any methodology.
Deliverable: A one-page readout whose first line is the recommendation.
Practice prompt ↗Practice prompt ↗Worked solution ↗Expand any day for tasks and deliverables. Your progress is saved on this device.
Nearly every data role forces a trade between the analysis you want and the one that fits the decision window. Prepare a case where you deliberately shipped something less rigorous, named the weakness to the person relying on it, and said what would change your answer. The naming is the part interviewers listen for.
Tell me about a time you had to collaborate with a global, cross-funct…
Tell me about a time you had to collaborate with a global, cross-functional team across different time zones to deliver a critical project.
Approach
- State the situation in two sentences and spend the rest on your reasoning.
- Quantify the outcome, including what you would not claim credit for.
- Name the disagreement or constraint, and how you resolved it with evidence.
Follow-up
- How did you know the outcome was caused by your change?
- What did you decide not to do, and why?
Scope a one-line request for a readmission rate
A clinical operations lead messages you: 'What is our readmission rate? The committee meets Friday.' You have encounter (encounter_id, admit_ts, discharge_ts, encounter_type, admission_type, discharge_disposition, drg_code, index_encounter_id) and member_enrollment coverage spans. Do not open a query editor yet. Deliverable: the three to five questions you send back, ranked by how much the answer moves the number; the default specification you will build if nobody replies by Wednesday; and the one line you will place under the figure so the committee does not read it against a published benchmark.
Approach
- Read the probe: this tests whether you convert ambiguity into a specification without either stalling or guessing silently. Both failure modes are common, and the silent guess is worse because nobody can see it.
- Rank your questions by leverage on the number rather than by curiosity. Whether the numerator is all-cause or unplanned, and whether the clock starts at discharge_ts, move the result far more than a tie-break rule on same-day returns.
- Ask about the comparison first. A number going to a committee will be compared to something, and whether that something is last quarter, another panel, or a national figure decides whether you owe them a raw rate, a risk-adjusted rate, or an observed-over-expected ratio.
- Commit to a default in writing so silence does not block you: unplanned acute inpatient readmission within 30 days of discharge_ts, index stays excluding planned admissions, acute-to-acute transfers, discharges against medical advice, and dispositions of expired or hospice, denominator of eligible index discharges, paid-through date stated.
- Write the caveat as a restriction on use rather than a hedge: name the one comparison the figure supports and the one it does not.
Follow-up
- They reply that they want it 'the way the benchmark does it'. What do you ask next?
- The committee wants it split by attending provider. What changes in the specification, and what do you refuse to show?
- How does your answer change if the meeting is tomorrow rather than Friday?
Disagree with a product manager about an adherence nudge
A product manager proposes shipping a refill-reminder feature to the whole member base, citing an internal analysis: members with 12-month proportion of days covered at or above 0.80 had 31 percent fewer admissions than members below it. The roadmap date is three weeks out and engineering is scoped. You believe the comparison builds survival and continuous coverage into the exposure definition, and is separately confounded by the kind of member who refills on time. Deliverable: what you say in the room, what you send afterwards, and the smallest study you would accept as sufficient to ship.
Approach
- The probe is whether you can be specific and non-territorial at once. A disagreement that arrives as 'the analysis is flawed' costs you the room; one that names a mechanism and offers a cheaper path keeps it.
- Name the two defects separately, because they have different fixes. Classifying a member as adherent over 12 months requires them to stay alive and stay covered for those 12 months, and that guaranteed event-free interval is assigned to the adherent group. Separately, members who refill on schedule differ from those who do not in ways claims never record.
- Show rather than assert. Rerun the same comparison as a landmark analysis: classify adherence over days 1 to 90, start follow-up at day 91 for everyone still enrolled and event-free, and report how much of the 31 percent survives.
- Separate the association claim from the intervention claim out loud. Nothing in the analysis speaks to whether a reminder changes refill behaviour, which is the actual product question and is separately testable.
- Offer the shippable path: a randomised holdout on a subset with proportion of days covered as the primary endpoint, powered on the plausible effect of a reminder rather than on the 31 percent, with a stated read date.
Follow-up
- The landmark rerun still shows a 20 percent difference. Do you ship?
- The product manager says a holdout delays launch. How do you cost that argument?
- What primary endpoint do you choose, and why not admissions?
- 01
Tell me about a time you had to collaborate with a global, cross-functional team across different time zones to deliver a critical project.
- 02
A clinical operations lead messages you: 'What is our readmission rate? The committee meets Friday.' You have encounter (encounter_id, admit_ts, discharge_ts, encounter_type, admission_type, discharge_disposition, drg_code, index_encounter_id) and member_enrollment coverage spans. Do not open a query editor yet. Deliverable: the three to five questions you send back, ranked by how much the answer moves the number; the default specification you will build if nobody replies by Wednesday; and the one line you will place under the figure so the committee does not read it against a published benchmark.
- 03
A product manager proposes shipping a refill-reminder feature to the whole member base, citing an internal analysis: members with 12-month proportion of days covered at or above 0.80 had 31 percent fewer admissions than members below it. The roadmap date is three weeks out and engineering is scoped. You believe the comparison builds survival and continuous coverage into the exposure definition, and is separately confounded by the kind of member who refills on time. Deliverable: what you say in the room, what you send afterwards, and the smallest study you would accept as sufficient to ship.
Is this an official Pfizer interview guide?
No. It is PracHub's own research and practice material for the Data Scientist role at Pfizer. Rounds and questions reflect what candidates have reported, not a process Pfizer has published, and they change over time. Confirm the current format and scope with your recruiter.
PracHub interview research ↗How difficult is the Data Scientist interview process at Pfizer?
The difficulty ranges from average to difficult depending on the team and seniority. Some commercial analytics roles focus heavily on practical SQL, Python, and digital analytics, making them relatively straightforward. In contrast, R&D and advanced AI roles involve rigorous multi-stage technical panels, live coding, and presentation rounds that require deep preparation.
PracHub interview research ↗What is the "TED-style presentation" round?
In some senior-level loops, candidates are asked to prepare and deliver a structured presentation detailing a complex data science project they have led. The focus is on your ability to tell a compelling story, explain your technical choices clearly, and highlight the business or clinical impact of your work to a panel of directors and peers.
PracHub interview research ↗Does Pfizer support remote or hybrid working arrangements?
Yes, Pfizer generally operates on a hybrid model, combining remote flexibility with in-office collaboration days. The exact expectations depend on your location, team, and local office policies.
PracHub interview research ↗How long does the entire interview process take from application to offer?
The timeline is typically efficient, often taking between 3 to 6 weeks. Many candidates report that once the formal interview rounds begin, they are scheduled back-to-back, and the team is highly structured with minimal lag in communicating evaluations.
PracHub interview research ↗Sources & methodology 3 sources ↗
No official company page is cited. Rounds and questions come from candidate reports and PracHub editorial material; each source shows the date it was read.
- 01PracHub interview research ↗
PracHub editorial research into this company and role, maintained with this guide. Candidate-reported, not an employer publication.
PracHub page · Accessed 2026-09-22 - 02PracHub Data Scientist practice ↗
Cross-company practice questions for this role.
PracHub page · Accessed 2026-09-22 - 03PracHub interview preparation framework ↗
The framework the preparation plan follows.
PracHub page · Accessed 2026-09-22
Explore related engineering environments and compare the preparation focus.
Veracyte Data Scientist Interview Questions & Guide 2026
Causal-inference exercises for Veracyte data scientist prep: difference-in-differences, matching, instrumental variables, and knowing when observational data simply cannot answer the question asked.
Zoetis Data Scientist Interview Questions & Guide 2026
Metric-diagnosis practice for Zoetis data scientist candidates: a number moves week over week and you work out why, splitting by segment, ruling out a logging or release change, and separating a mix shift from a real change in user behaviou
Vizient Data Scientist Interview Questions & Guide 2026
Communication practice for Vizient data scientist candidates: turn an analysis into a recommendation, name the uncertainty honestly, and answer the follow-up a skeptical stakeholder will raise.
Vibrant Emotional Health Data Scientist Interview Questions & Guide 2026
Case practice for the Vibrant Emotional Health data scientist interview, where the prompt is deliberately underspecified and your first move is scoping it into something measurable.